| Patents for A61P 11 - Drugs for disorders of the respiratory system (87,767) |
|---|
| 04/30/2009 | WO2009052708A1 1-(3-amino-propyl)-piperidin-4-yl-amides, pharmaceutical compositions, processes for their preparation and uses |
| 04/30/2009 | WO2009052630A1 Compositions and methods for treating fibroproliferative disorders |
| 04/30/2009 | WO2009052625A1 Novel crystalline salts of montelukast |
| 04/30/2009 | WO2009052624A1 Inhalation compositions comprising montelukast acid and a pde-4 inhibitor or an inhaled corticosteroid |
| 04/30/2009 | WO2009033733A3 Use of apeptide as a therapeutic agent |
| 04/30/2009 | WO2009031011A3 Xinafoate salt of n4-(2, 2-difluoro-4h-benz0 [1,4] 0xazin-3-one) -6-yl] -5-fluoro-n2- [3- (methylaminocar bonylmethyleneoxy) phenyl] 2, 4-pyrimidinediamine |
| 04/30/2009 | WO2009027069A3 Osmolytes for the treatment of allergic or viral respiratory diseases |
| 04/30/2009 | WO2008141119A3 Modulators of cftr |
| 04/30/2009 | WO2008138889A3 3, 6-disubstituted-imidazo [1, 2-b] pyridazines and 3, 5-disubstituted pyrazolo[1, 5-a] pyrimidines as phosphatidylinositol-3-kinase inhibitors |
| 04/30/2009 | WO2008046598A8 DERIVATIVES OF 4-(2-AMINO-1-HYDROXYETHYL)PHENOL AS AGONISTS OF THE β2 ADRENERGIC RECEPTOR |
| 04/30/2009 | WO2007014327A3 Small compounds that correct protein misfolding and uses thereof |
| 04/30/2009 | WO2005010169A3 High throughput or capillary-based screening for a bioactivity or biomolecule |
| 04/30/2009 | WO2004092199A3 Method for identifying modulators of g protein coupled receptor signaling |
| 04/30/2009 | US20090111879 Administering N-(2,6-Dichlorobenzoyl)-4-(2,6-dimethoxy-4-methoxymethylphenyl)-L-phenylalanine ethyl ester for therapy of asthma, inflammatory bowel disease, rheumatoid arthritis and atopic dermatitis |
| 04/30/2009 | US20090111867 Indole acetic acids exhibiting crth2 receptor antagonism and uses thereof |
| 04/30/2009 | US20090111850 Amino-Substituted Ethylamino Beta2 Adrenergic Receptor Agonists |
| 04/30/2009 | US20090111795 Multimers of Heterocyclic Compounds and Their Use |
| 04/30/2009 | US20090111788 Antibiotic compositions of modified release and process of production thereof |
| 04/30/2009 | US20090111773 Compositions and methods of using lamellar bodies for modifying linear biological macromolecules |
| 04/30/2009 | US20090110756 Methods and Compositions Related to PLUNC Surfactant Polypeptides |
| 04/30/2009 | CA2704100A1 Compositions and methods for treating fibroproliferative disorders |
| 04/30/2009 | CA2703739A1 Compositions and methods for treating cystic fibrosis |
| 04/30/2009 | CA2703329A1 Use of trkb antibodies for the treatment of respiratory disorders |
| 04/30/2009 | CA2703230A1 Novel crystalline forms |
| 04/30/2009 | CA2703179A1 Liposomal vancomycin formulations |
| 04/30/2009 | CA2702447A1 New phenyl-substituted piperazino-dihydrothienopyrimidines |
| 04/30/2009 | CA2701956A1 Combination therapy |
| 04/30/2009 | CA2701723A1 Novel crystalline salts of montelukast |
| 04/29/2009 | EP2053043A1 Crystalline salt of montelukast |
| 04/29/2009 | EP2053038A1 Aminoalcohol derivative and immunosuppressant containing the same as an active ingredient |
| 04/29/2009 | EP2051714A1 Drug combinations for the treatment of respiratory tract diseases |
| 04/29/2009 | EP2051712A2 Modulators of muscarinic receptors |
| 04/29/2009 | EP1446379B1 Aryl aniline beta-2 adrenergic receptor agonists |
| 04/29/2009 | EP1438288B1 Substituted thioacetamides |
| 04/29/2009 | EP1345910B1 Quinazoline derivatives, medicaments containing said compounds, their utilization and method for the production thereof |
| 04/29/2009 | EP1218509B1 Fibroblast growth factor-like polypeptides |
| 04/29/2009 | EP1066286B1 Heterocyclo-substituted imidazopyrazine protein tyrosine kinase inhibitors |
| 04/29/2009 | CN101421252A 2,6-substituted-4-monosubstituted amino-pyrimidine as prostaglandin D2 receptor antagonists |
| 04/29/2009 | CN101420966A Use of non-digestable sacharides for giving an infant the best start after birth |
| 04/29/2009 | CN101420955A Dihydrodiazepines useful as inhibitors of protein kinases |
| 04/29/2009 | CN101418334A Diterpenes diterpenoids natural product inhibitor for main protease of coronaviruses such as SARS and screen method thereof |
| 04/29/2009 | CN101417129A Gabapentin analogues for fibromyalgia and other related disorders |
| 04/29/2009 | CN101417122A Recombination chicken alpha-interferon injection and preparation method thereof |
| 04/29/2009 | CN101417113A Traditional Chinese medicine for treating chronic pharyngitis |
| 04/29/2009 | CN101417076A Oral traditional Chinese medicine formulation for treating throat disease |
| 04/29/2009 | CN101417075A Traditional Chinese medicine for treating respiratory system disease |
| 04/29/2009 | CN101417065A Oral traditional Chinese medicine formulation for treating chronic tracheitis |
| 04/29/2009 | CN101417055A Traditional Chinese medicine for treating wean bronchial asthma and preparation method thereof |
| 04/29/2009 | CN101417053A Wean bathing liquor capable of eliminating sputum and refrigerating |
| 04/29/2009 | CN101417032A Traditional Chinese medicine composition for treating infectious larngotracheitis |
| 04/29/2009 | CN101417031A Preparation method of animal medicine capable of clearing away the heat-evil and expelling the superficial evils, relieving cough and asthma |
| 04/29/2009 | CN101417006A Preparation method of animal medicine capable of increasing animal immunity and reducing stress reaction |
| 04/29/2009 | CN101416997A Preparation technique of traditional Chinese medicine |
| 04/29/2009 | CN101416992A Beggarticks dispersion tablets and preparation method thereof |
| 04/29/2009 | CN101416956A Ambroxol hydrochloride injection |
| 04/29/2009 | CN100482664C 1,5-disubstituted-3,4-dihydro-1H-pyrimido [4,5-D] pyrimidi-2-one compounds and their use in treating CSBP/P38 kinase mediated diseases |
| 04/29/2009 | CN100482651C Diaminothiazoles |
| 04/29/2009 | CN100482646C Derivative of n-[phenyl(piperidin-2-yl)methyl]benzamide, the preparation method thereof and application of same in therapeutics |
| 04/29/2009 | CN100482281C Method of treatment using anti-ErbB antibody-maytansinoid conjugates |
| 04/29/2009 | CN100482279C Chinese herb medicine composition in the form of jelly |
| 04/29/2009 | CN100482276C Antibody selective for a tumor necrosis factor-related apoptosis-inducing ligand receptor and uses thereof |
| 04/29/2009 | CN100482262C Herbal pharmaceutical compositions for treating immun logical disorders |
| 04/29/2009 | CN100482234C Stibene-glucoside oral liquid and its production method |
| 04/29/2009 | CN100482227C Sustained release compound capsules and its preparation method |
| 04/29/2009 | CN100482216C Use of hydroxide-releasing agents as skin permeation enhancers |
| 04/29/2009 | CN100482208C Compound licorice medicine prepn and its prepn process |
| 04/29/2009 | CN100482207C Novel lipid mixtures for synthetic surfactants |
| 04/29/2009 | CN100482129C Health care medicated pillow |
| 04/28/2009 | US7524949 Prevention or therapy of cardiovascular complications |
| 04/28/2009 | US7524880 Napadisylate salt formation of 2-[(S)-1-(8-methylaminooctyl)pyrrolidin-3-yl]-2,2-diphenylacetamide in an aqueous isopropanol or ethanol solution; chronic obstructive pulmonary disorder, asthma; muscarinic receptor antagonists |
| 04/28/2009 | US7524874 Vanilloid receptor ligands and their use in treatments |
| 04/28/2009 | US7524858 Substituted pyrroline kinase inhibitors |
| 04/28/2009 | US7524852 Bicyclic pyrimidine derivatives |
| 04/28/2009 | US7524841 4,4-disubstituted piperidine derivatives having CCR3 antagonism |
| 04/28/2009 | US7524836 steroids such as (11 beta )-11-17-dihydroxy-21-[N-acetyl-S-(4-nitroxybutyroyl) cisteinyloxy]pregne-1,4-diene-3,20-dione having antiinflammatory, immunodepressive and angiostatic activity |
| 04/28/2009 | US7524834 Antiinflammatory and antiallergic glucocorticosteroid, sterile glucocorticosteroids |
| 04/28/2009 | US7524830 Decoy-containing pharmaceutical compositions and method of using the same |
| 04/28/2009 | US7524828 Immunostimulatory nucleic acid molecules |
| 04/28/2009 | US7524815 Bovine or colostrum; milk, yogurt, curd, cheese, fermented milks, milk-based fermented products, ice creams, fermented cereal-based products, milk-based powders, infant formula, pet food; Osteoporosis, Paget's Disease, hypercalcemia, bone loss from arthritis, necrosis, or periodontal disease |
| 04/28/2009 | US7524679 Methods for culturing human lung mast cells and uses thereof |
| 04/28/2009 | US7524675 Administering a polynucleotide encoding a Mycrobacterium kansasii-derived alpha antigen; asthma, atopic dermatitis, allergic rhinitis, allergic conjunctivitis |
| 04/28/2009 | US7524517 Methods and compositions for P2X receptor calcium entry channels and other calcium entry mechanisms |
| 04/28/2009 | CA2418506C Method for identifying substances which positively influence inflammatory conditions of chronic inflammatory airway diseases |
| 04/28/2009 | CA2380074C Novel amide derivatives |
| 04/28/2009 | CA2375259C Bicyclic heterocycles, pharmaceutical compositions containing these compounds, their use and processes for preparing them |
| 04/28/2009 | CA2336783C Novel 2,3,3a,4,9,9a hexahydro-8-hydroxy-1h-benz[f]indoles, a method for the production thereof, and their use as medicaments |
| 04/28/2009 | CA2334761C Composition comprising .beta.-hydroxy-.beta.-methylbutyric acid and at least one amino acid and methods of use |
| 04/28/2009 | CA2135614C Use of urodilatin in pulmonary and bronchial diseases |
| 04/23/2009 | WO2009052310A1 A3 adenosine receptor antagonists |
| 04/23/2009 | WO2009052081A2 Antibodies that bind il-4 and/or il-13 and their uses |
| 04/23/2009 | WO2009051909A1 Compounds having activity in correcting mutant-cftr cellular processing and uses thereof |
| 04/23/2009 | WO2009051618A1 Treatment of asthma and chronic obstructive pulmonary disease with anti-proliferate and anti-inflammatory drugs |
| 04/23/2009 | WO2009051556A1 Tetrazole derivatives as modulators of metabotropic glutamate receptors (mglurs) |
| 04/23/2009 | WO2009050348A1 Tricyclic n-heteroaryl-carboxamide derivatives, preparation thereof and therapeutic use of same |
| 04/23/2009 | WO2009050248A1 Substituted piperidino-dihydrothienopyrimidines |
| 04/23/2009 | WO2009050244A1 Indazoles as glucocorticoid receptor ligands |
| 04/23/2009 | WO2009050243A1 Indazoles as glucocorticoid receptor ligands |
| 04/23/2009 | WO2009050242A2 Heterocycle-substituted piperazino-dihydrothienopyrimidines |
| 04/23/2009 | WO2009050236A1 Novel piperazino-dihydrothienopyrimidine derivatives |
| 04/23/2009 | WO2009050221A1 Indazoles as glucocorticoid receptor ligands |